High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.8M
$1,772,501
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| IMVT |
Immunovant, Inc.
|
COO
Sell to Cover
|
2026-02-25 | $90,184x3 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
CTO
Sell to Cover
|
2026-01-21 | $51,461 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
CTO
Sell to Cover
|
2026-01-07 | $31,914x2 | S | Form 4 |
|
IMVT
S
Immunovant, Inc.
Van Tuyl Christopher
• Officer • Chief Legal Officer
Sell to Cover
2025-12-18
$290,943x2
|
||||||
| IMVT |
Immunovant, Inc.
|
Officer • Chief Legal Officer
Sell to Cover
|
2025-12-18 | $290,943x2 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
Director
10b5-1 Sell
|
2025-12-01 | $517,189x2 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
Director
10b5-1 Sell
|
2025-12-01 | $348,665x2 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
COO
Sell to Cover
|
2025-11-20 | $298,237x2 | S | Form 4 |
|
IMVT
S
Immunovant, Inc.
Geffner Michael
• Officer • Chief Medical Officer
Sell to Cover
2025-10-22
$49,383
|
||||||
| IMVT |
Immunovant, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2025-10-22 | $49,383 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
CTO
Sell to Cover
|
2025-10-22 | $47,956 | S | Form 4 |
|
IMVT
S
Immunovant, Inc.
Geffner Michael
• Officer • Chief Medical Officer
Sell to Cover
2025-10-08
$20,734
|
||||||
| IMVT |
Immunovant, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2025-10-08 | $20,734 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
CTO
Sell to Cover
|
2025-10-08 | $25,836 | S | Form 4 |